Sherif El-Nashar, MD, PhD
OB/GYN-Female Pelvic Medicine and Reconstructive Surgery
Associate Professor, Obstetrics and Gynecology, CWRU School of Medicine
UH Cleveland Medical Center
Department of OB/GYN-Female Pelvic Medicine and Reconstructive Surgery
11100 Euclid Ave
5850 Landerbrook Dr
UH Landerbrook Health Center, Ste 210
UH Westlake Health Center
960 Clague Rd
6115 Powers Blvd
UH Samaritan Medical Center
1025 Center St
Pelvic Organ Prolapse, Female Pelvic Reconstructive Surgery, Pelvic Pain and Chronic Pain Disorders, Bladder Botox Injections, Minimally Invasive Gynecologic Surgery, Pelvic Floor Issues in Cancer Survivors, Bladder Pain Syndrome, Urinary Incontinence, Accidental Bowel Leakage, Sacral Neuromodulation, Female Pelvic Medicine, Urogynecology, Pelvic Floor Issues After Childbirth, Non-Relaxing Pelvic Floor Disorders, Urogenital Disorders Related to Menopause
American Board of Obstetrics and Gynecology - Obstetrics and Gynecology
American Board of Obstetrics and Gynecology - Female Pelvic Medicine and Reconstructive Surgery
Education & Training
Medical / Professional School(s):
1997, Assiut University Faculty of Medicine
2012, Obstetrics and Gynecology - Mayo Clinic
2015, Female Pelvic Surgery - Mayo Clinic
2008, Gynecology - Mayo Clinic
Patient Satisfaction Reviews
About Our Survey
At University Hospitals, we believe in providing patients with all the information they need to make educated decisions about their health care and to choose the right doctor to meet their needs. That is why we partner with the independent patient satisfaction company Press Ganey to survey patients about their experiences at UH facilities and with UH physicians. We hold ourselves to the highest standards of care and are dedicated to creating a positive patient experience for every individual who sees a UH doctor.
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Sherif El-Nashar, MD, PhD did not disclose any Outside Relationships with Industry.